Established in 2019, this privately held specialty chemical company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and cosmetic ingredients. Operating from an 80,000-litre owned facility in South India, the company caters to niche B2B clients in the pharmaceutical and skincare sectors.

Key Highlights:

• 3X revenue growth in 2 years
• Top SKUs: Methyl Propanoate derivatives, Diethylhexyl Butamide Triazone, Ethyl Hexyl Triazone
• Facility Utilization: 60–70%, with strong scalability potential
• Licenses in place: API Test License, Drug License, Environmental Clearance
• Workforce: 45 permanent + contract staff
• Promoter with 27+ years of pharma industry experience
• Clean regulatory standing, compliant infrastructure
• Current liabilities: INR 14 Cr term loan + INR 6 Cr CC

Assets Overview
Tangible assets:
- Land: INR 3 crore
- Plant and machinery: INR 40 crores

Facilities Overview
Operates from an owned facility

• Total land area: 5 acres.
• Built-up area: 44,000 sq. ft.

Products & Services

1. Anti-depressants
2. Anti-allergy APIs
3. Oncology & Pain management ingredients
4. UV filters for cosmetics

Industry Pharmaceuticals	Sub Industry Pharmaceutical Manufacturing (Bulk Drug & API)
Nature of Business B2B	Sector Manufacturing (Contract Manufacturing)
Reason for sell-off Financial or Operational Challenges
Location India	Region Southern
Open For Dilution 100 % (Complete Buyout)	Top Customer
Deal Size INR 45 - 50 Cr	Justification Based on market multiple. Includes physical assets worth INR 43 crore

Teaser

To send interest please follow below steps

1	Open this link
2	To login to your MergerDomo account, enter your login id and password. If you haven't registered yet, please register.
3	Click on Express Interest to send interest on the deal.